NCT07577609

Brief Summary

The goal of this observational study is to learn if AI-assisted cardiac CT imaging can improve cardiovascular risk stratification and prediction of future coronary events in an adult population undergoing clinically indicated cardiac CT. The main questions it aims to answer are:

  • Can AI-enhanced cardiac CT accurately assess cardiovascular risk in a real-world adult population?
  • How do CT-derived plaque characteristics correlate with clinical, biochemical, and lifestyle risk factors? Researchers will compare subgroups (e.g., patients with different risk profiles, biomarkers, or imaging findings, and a subset undergoing OCT imaging) to see if differences in imaging and clinical parameters are associated with cardiovascular risk and plaque vulnerability. Participants will:
  • Provide informed consent and medical history/demographic information
  • Undergo blood sampling for cardiovascular and metabolic biomarkers
  • Have a resting ECG performed
  • Complete a detailed lifestyle and health questionnaire
  • Receive a non-invasive cardiac CT scan interpreted by an expert
  • Potentially receive heart rate-lowering medication (e.g., metoprolol) if required for imaging quality
  • Be referred for further clinical evaluation if clinically indicated 

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
80mo left

Started Dec 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Dec 2022Dec 2032

Study Start

First participant enrolled

December 21, 2022

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2032

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

10 years

First QC Date

April 28, 2026

Last Update Submit

May 5, 2026

Conditions

Keywords

AI-assisted cardiac CTCoronary CT angiography (CCTA)Cardiovascular risk stratificationCoronary plaque characterizationHigh-risk plaqueMachine learningCT-FFR (fractional flow reserve)Coronary calcium scoring

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular risk stratification using AI-assisted cardiac CT

    Assessment of cardiovascular risk based on AI-enhanced cardiac CT imaging, including coronary artery calcium scoring, plaque characterization, and integrated risk prediction using clinical and imaging data.

    Baseline

Secondary Outcomes (6)

  • Correlation between CT-derived plaque characteristics and haematological biomarkers

    Baseline

  • Concordance between coronary CT angiography (CCTA) and optical coherence tomography (OCT)

    Baseline (subset undergoing OCT)

  • Association between lifestyle factors and imaging-derived plaque risk features

    Baseline

  • Subgroup analyses of cardiovascular risk by demographic and clinical factors

    Baseline

  • Longitudinal changes in plaque composition in patients receiving statin therapy

    Baseline, 1 year, and annually up to 5 years

  • +1 more secondary outcomes

Other Outcomes (1)

  • Development of an anonymized multimodal dataset for AI training and validation

    through study completion, up to 10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All-comers adult population undergoing clinically indicated cardiac CT in routine clinical care

You may qualify if:

  • Adults aged ≥18 years
  • Undergoing clinically indicated cardiac CT
  • Able and willing to provide informed consent

You may not qualify if:

  • History of malignancy
  • Abnormal renal function (e.g., eGFR or serum creatinine outside reference range)
  • Contraindications to iodinated contrast agents or CT imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Research Facility

Galway, Ireland

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseMyocardial Ischemia

Condition Hierarchy (Ancestors)

Coronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Faisal Sharif, MBBS, PhD, FRCPI, FESC, FACC

    University of Galway

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 11, 2026

Study Start

December 21, 2022

Primary Completion (Estimated)

December 21, 2032

Study Completion (Estimated)

December 21, 2032

Last Updated

May 11, 2026

Record last verified: 2026-05

Locations